A carregar...

Pharmacokinetics of Antituberculosis Drugs in Pulmonary Tuberculosis Patients with Type 2 Diabetes

Altered pharmacokinetics of antituberculosis drugs may contribute to an increased risk of tuberculosis treatment failure for diabetic patients. We previously found that rifampin exposure was 2-fold lower in diabetic than in nondiabetic tuberculosis patients during the continuation phase of treatment...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Ruslami, Rovina, Nijland, Hanneke M. J., Adhiarta, I. Gusti N., Kariadi, Sri H. K. S., Alisjahbana, Bachti, Aarnoutse, Rob E., van Crevel, Reinout
Formato: Artigo
Idioma:Inglês
Publicado em: American Society for Microbiology (ASM) 2010
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2825975/
https://ncbi.nlm.nih.gov/pubmed/20038625
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.00447-09
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!